THERAPEUTIC TARGETING OF THE ATAD2 ONCOGENE IN OVARIAN CANCER

$376,480FY2022Defense Health AgencyDOD

The Medical University Of South Carolina

Investigators

View source on USAspending →

THERAPEUTIC TARGETING OF THE ATAD2 ONCOGENE IN OVARIAN CANCER · GrantIndex